Close Menu

sequencing by expansion

The precision medicine company also is accelerating its push into diabetes, depression, and cardiology after getting its solid-tumor test turnaround down to 9 days. 

The firm said recent breakthroughs in its technology will enable sequencing "at commercially compelling levels of read length, accuracy, process speed, and workflow efficiency." 

Early research has shown the open-source ExpansionHunter software to be highly accurate in identifying repeat expansions that indicate rare diseases.

Stratos reached its milestone by demonstrating nanopore sequencing with its proprietary expandable nucleotides, called X-NTPs.

NEW YORK (GenomeWeb) – When Roche announced last month that it planned to acquire nanopore sequencing startup Genia for up to $350 million, unbeknownst to the public

NEW YORK (GenomeWeb) — Roche said today that it has made a strategic investment in nanopore sequencing startup Stratos Genomics and is collaborating to further develop the firm's sequencing chemistry.

After developing the chemistry for its sequencing-by-expansion nanopore technology for several years, Stratos Genomics is ready to grow its development and commercialization efforts.

NEW YORK (GenomeWeb News) – Stratos Genomics today announced it has closed on $2 million in financing to support the further development of, and "strategic discussions" related to the Seattle-based firm's DNA sequencing technology.

Stratos converts DNA into a longer polymer called an "Xpandomer," which encodes the base sequence through reporter molecules that have a high signal-to-noise ratio.

The funding follows $4 million raised last year and will be used to further develop the firm's ultra-low-cost nucleic acid sequencing technology.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.